Johansen, Mette L.
Vincent, Jason
Rose, Marissa
Sloan, Andrew E.
Brady-Kalnay, Susann M. http://orcid.org/0000-0003-4635-4093
Funding for this research was provided by:
NIH (R01CA217956)
Article History
Received: 21 September 2022
Revised: 2 January 2023
Accepted: 3 January 2023
First Online: 25 January 2023
Declarations
:
: Dr. Brady-Kalnay has licensed these agents to the biotechnology company NeoIndicate, where she serves as the Chief Scientific Officer. Mette Johansen is an inventor on the relevant patents.